Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Beijing Tong Ren Tang Chinese Medicine Co Ltd banner
B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 5.565 HKD -0.27% Market Closed
Market Cap: HK$4.7B
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd

Wall Street analysts forecast Beijing Tong Ren Tang Chinese Medicine Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 10.455 HKD with a low forecast of 10.1 HKD and a high forecast of 11.025 HKD.

Lowest Forecast
Wall Street Target
HK$10.1
81% Upside
Average Forecast
Wall Street Target
HK$10.455
88% Upside
Highest Forecast
Wall Street Target
HK$11.025
98% Upside
Lowest Forecast
Price Target
10.1 HKD
81% Upside
Average Forecast
Price Target
10.455 HKD
88% Upside
Highest Forecast
Price Target
11.025 HKD
98% Upside
Beijing Tong Ren Tang Chinese Medicine Co Ltd Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

11% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
11% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%.

What are analyst estimates?

Operating Income
Forecast

12% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
12% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 23%.

What are analyst estimates?

Pre-Tax Income
Forecast

12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

What are analyst estimates?

Net Income
Forecast

7% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 23%.

What are analyst estimates?

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Beijing Tong Ren Tang Chinese Medicine Co Ltd listings:
OTC • USD
BJTRF
 F • EUR
TQR
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's stock price target?
Price Target
10.455 HKD

According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 10.455 HKD with a low forecast of 10.1 HKD and a high forecast of 11.025 HKD.

What is the Revenue forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 23%.

What is the Pre-Tax Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 24%.

What is the Net Income forecast for Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.